Stem cell biotech Novoheart is to collaborate with AstraZeneca to develop a “heart in a jar” that will be used to help develop new heart failure drugs.
A collaboration between Biofabri, a non-profit organisation, and academics from South Africa are pressing ahead with clinical development of a novel tuberculosis vaccine candidate known as
